Learning Tracks

Drug shortages continue to challenge patient care, healthcare practitioners, and generic manufacturers, despite ongoing efforts to strengthen the U.S. pharmaceutical supply chain. While new shortages have declined, recent data underscores a continuing year over year trend: long-term shortages are lasting longer, product discontinuations are increasing, and vulnerabilities often originate far upstream in the supply chain.

This session will bring together industry leaders, policymakers, and supply chain experts to examine the latest shortage data, discuss lessons learned from persistent shortages affecting essential generic medicines, and explore solutions that better align market incentives with supply chain resilience. Panelists will consider emerging policy proposals, opportunities to strengthen domestic and diversified manufacturing, the growing importance of supply chain transparency, and how stakeholders across the healthcare ecosystem can work together to reduce future shortages.

Craig Burton
Senior Vice President, Government Affairs, Fresenius Kabi USA

Stephen Colvill
Assistant Policy Research Director, Duke-Margolis Institute for Health Policy

Michael Ganio, PharmD
Senior Director, Pharmacy Practice and Quality, ASHP

Kim Trzeciak 
Vice President, Global External Affairs, USP